vs
Hub Group, Inc.（HUBG）与Revvity（RVTY）财务数据对比。点击上方公司名可切换其他公司
Hub Group, Inc.的季度营收约是Revvity的1.2倍（$934.5M vs $772.1M），Revvity净利率更高（12.7% vs 3.1%，领先9.7%），Revvity同比增速更快（5.9% vs -5.3%），Revvity自由现金流更多（$161.8M vs $19.4M），过去两年Revvity的营收复合增速更高（9.0% vs -2.6%）
Hub Group是北美知名的运输与物流管理企业，1971年由菲利普·耶格尔创立，1996年上市，总部位于伊利诺伊州奥克布鲁克，目前由创始人之孙菲利普·D·耶格尔运营，年营收超50亿美元，为客户提供专业的供应链及物流解决方案。
Revvity是一家美国生命科学与诊断领域企业，主要服务制药、生物技术行业客户，重点围绕细胞治疗、基因治疗等前沿技术领域提供相关产品与解决方案，其前身为业务布局多元的老牌企业珀金埃尔默。
HUBG vs RVTY — 直观对比
营收规模更大
HUBG
是对方的1.2倍
$772.1M
营收增速更快
RVTY
高出11.2%
-5.3%
净利率更高
RVTY
高出9.7%
3.1%
自由现金流更多
RVTY
多$142.4M
$19.4M
两年增速更快
RVTY
近两年复合增速
-2.6%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $934.5M | $772.1M |
| 净利润 | $28.6M | $98.4M |
| 毛利率 | — | — |
| 营业利润率 | 4.2% | 14.5% |
| 净利率 | 3.1% | 12.7% |
| 营收同比 | -5.3% | 5.9% |
| 净利润同比 | 21.0% | 3.9% |
| 每股收益（稀释后） | $0.47 | $0.86 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HUBGRVTY
| Q4 25 | — | $772.1M | ||
| Q3 25 | $934.5M | $698.9M | ||
| Q2 25 | $905.6M | $720.3M | ||
| Q1 25 | $915.2M | $664.8M | ||
| Q4 24 | $973.5M | $729.4M | ||
| Q3 24 | $986.9M | $684.0M | ||
| Q2 24 | $986.5M | $691.7M | ||
| Q1 24 | $999.5M | $649.9M |
净利润HUBGRVTY
| Q4 25 | — | $98.4M | ||
| Q3 25 | $28.6M | $46.7M | ||
| Q2 25 | $25.2M | $53.9M | ||
| Q1 25 | $26.8M | $42.2M | ||
| Q4 24 | $24.3M | $94.6M | ||
| Q3 24 | $23.6M | $94.4M | ||
| Q2 24 | $29.0M | $55.4M | ||
| Q1 24 | $27.1M | $26.0M |
毛利率HUBGRVTY
| Q4 25 | — | — | ||
| Q3 25 | — | 53.6% | ||
| Q2 25 | — | 54.5% | ||
| Q1 25 | — | 56.5% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 56.3% | ||
| Q2 24 | — | 55.7% | ||
| Q1 24 | — | 54.6% |
营业利润率HUBGRVTY
| Q4 25 | — | 14.5% | ||
| Q3 25 | 4.2% | 11.7% | ||
| Q2 25 | 3.8% | 12.6% | ||
| Q1 25 | 4.1% | 10.9% | ||
| Q4 24 | 3.2% | 16.3% | ||
| Q3 24 | 3.3% | 14.3% | ||
| Q2 24 | 4.0% | 12.4% | ||
| Q1 24 | 3.7% | 6.8% |
净利率HUBGRVTY
| Q4 25 | — | 12.7% | ||
| Q3 25 | 3.1% | 6.7% | ||
| Q2 25 | 2.8% | 7.5% | ||
| Q1 25 | 2.9% | 6.4% | ||
| Q4 24 | 2.5% | 13.0% | ||
| Q3 24 | 2.4% | 13.8% | ||
| Q2 24 | 2.9% | 8.0% | ||
| Q1 24 | 2.7% | 4.0% |
每股收益（稀释后）HUBGRVTY
| Q4 25 | — | $0.86 | ||
| Q3 25 | $0.47 | $0.40 | ||
| Q2 25 | $0.42 | $0.46 | ||
| Q1 25 | $0.44 | $0.35 | ||
| Q4 24 | $0.40 | $0.77 | ||
| Q3 24 | $0.39 | $0.77 | ||
| Q2 24 | $0.47 | $0.45 | ||
| Q1 24 | $0.44 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $119.7M | $919.9M |
| 总债务越低越好 | $255.0M | — |
| 股东权益账面价值 | $1.7B | $7.3B |
| 总资产 | $2.9B | $12.2B |
| 负债/权益比越低杠杆越低 | 0.15× | — |
8季度趋势，按日历期对齐
现金及短期投资HUBGRVTY
| Q4 25 | — | $919.9M | ||
| Q3 25 | $119.7M | $931.4M | ||
| Q2 25 | $137.0M | $991.8M | ||
| Q1 25 | $112.7M | $1.1B | ||
| Q4 24 | $98.2M | $1.2B | ||
| Q3 24 | $186.1M | $1.2B | ||
| Q2 24 | $220.2M | $2.0B | ||
| Q1 24 | $195.4M | $1.7B |
总债务HUBGRVTY
| Q4 25 | — | — | ||
| Q3 25 | $255.0M | — | ||
| Q2 25 | $231.9M | — | ||
| Q1 25 | $252.1M | — | ||
| Q4 24 | $264.4M | — | ||
| Q3 24 | $287.1M | — | ||
| Q2 24 | $313.1M | — | ||
| Q1 24 | $334.8M | — |
股东权益HUBGRVTY
| Q4 25 | — | $7.3B | ||
| Q3 25 | $1.7B | $7.4B | ||
| Q2 25 | $1.7B | $7.6B | ||
| Q1 25 | $1.6B | $7.6B | ||
| Q4 24 | $1.6B | $7.7B | ||
| Q3 24 | $1.6B | $7.9B | ||
| Q2 24 | $1.6B | $7.9B | ||
| Q1 24 | $1.6B | $7.8B |
总资产HUBGRVTY
| Q4 25 | — | $12.2B | ||
| Q3 25 | $2.9B | $12.1B | ||
| Q2 25 | $2.8B | $12.4B | ||
| Q1 25 | $2.8B | $12.4B | ||
| Q4 24 | $2.9B | $12.4B | ||
| Q3 24 | $2.8B | $12.8B | ||
| Q2 24 | $2.9B | $13.4B | ||
| Q1 24 | $2.9B | $13.4B |
负债/权益比HUBGRVTY
| Q4 25 | — | — | ||
| Q3 25 | 0.15× | — | ||
| Q2 25 | 0.14× | — | ||
| Q1 25 | 0.15× | — | ||
| Q4 24 | 0.16× | — | ||
| Q3 24 | 0.18× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.21× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $28.1M | $182.0M |
| 自由现金流经营现金流 - 资本支出 | $19.4M | $161.8M |
| 自由现金流率自由现金流/营收 | 2.1% | 21.0% |
| 资本支出强度资本支出/营收 | 0.9% | 2.6% |
| 现金转化率经营现金流/净利润 | 0.98× | 1.85× |
| 过去12个月自由现金流最近4个季度 | $113.4M | $509.4M |
8季度趋势，按日历期对齐
经营现金流HUBGRVTY
| Q4 25 | — | $182.0M | ||
| Q3 25 | $28.1M | $138.5M | ||
| Q2 25 | $61.5M | $134.3M | ||
| Q1 25 | $70.0M | $128.2M | ||
| Q4 24 | $604.0K | $174.2M | ||
| Q3 24 | $43.4M | $147.9M | ||
| Q2 24 | $69.9M | $158.6M | ||
| Q1 24 | $80.5M | $147.6M |
自由现金流HUBGRVTY
| Q4 25 | — | $161.8M | ||
| Q3 25 | $19.4M | $120.0M | ||
| Q2 25 | $50.2M | $115.5M | ||
| Q1 25 | $50.8M | $112.2M | ||
| Q4 24 | $-7.0M | $149.8M | ||
| Q3 24 | $31.4M | $125.6M | ||
| Q2 24 | $56.2M | $136.6M | ||
| Q1 24 | $63.0M | $129.7M |
自由现金流率HUBGRVTY
| Q4 25 | — | 21.0% | ||
| Q3 25 | 2.1% | 17.2% | ||
| Q2 25 | 5.5% | 16.0% | ||
| Q1 25 | 5.6% | 16.9% | ||
| Q4 24 | -0.7% | 20.5% | ||
| Q3 24 | 3.2% | 18.4% | ||
| Q2 24 | 5.7% | 19.7% | ||
| Q1 24 | 6.3% | 20.0% |
资本支出强度HUBGRVTY
| Q4 25 | — | 2.6% | ||
| Q3 25 | 0.9% | 2.6% | ||
| Q2 25 | 1.2% | 2.6% | ||
| Q1 25 | 2.1% | 2.4% | ||
| Q4 24 | 0.8% | 3.4% | ||
| Q3 24 | 1.2% | 3.3% | ||
| Q2 24 | 1.4% | 3.2% | ||
| Q1 24 | 1.8% | 2.7% |
现金转化率HUBGRVTY
| Q4 25 | — | 1.85× | ||
| Q3 25 | 0.98× | 2.97× | ||
| Q2 25 | 2.44× | 2.49× | ||
| Q1 25 | 2.61× | 3.03× | ||
| Q4 24 | 0.02× | 1.84× | ||
| Q3 24 | 1.84× | 1.57× | ||
| Q2 24 | 2.41× | 2.87× | ||
| Q1 24 | 2.98× | 5.67× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HUBG
| Intermodal | $561.5M | 60% |
| Other | $343.6M | 37% |
| Inter Segment | $29.4M | 3% |
RVTY
| Immunodiagnostics | $240.8M | 31% |
| Life Sciences | $191.4M | 25% |
| Reproductive Health | $149.3M | 19% |
| Segment Operating Income | $132.0M | 17% |
| Software | $62.3M | 8% |
